Cargando…
Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives
BACKGROUND: Colorectal cancer (CRC) is one of the most frequent and deadly malignancies worldwide. This specific pathology is composed of various molecular entities, with distinct immunological phenotypes. In addition to KRAS, NRAS, and BRAF mutation status, other druggable alterations such as those...
Autores principales: | Motta, Rodrigo, Cabezas-Camarero, Santiago, Torres-Mattos, Cesar, Riquelme, Alejandro, Calle, Ana, Figueroa, Alejandro, Sotelo, Miguel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445628/ https://www.ncbi.nlm.nih.gov/pubmed/34541365 |
Ejemplares similares
-
Personalizing first-line treatment in advanced colorectal cancer: Present status and future perspectives
por: Motta, Rodrigo, et al.
Publicado: (2021) -
Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016) -
Mitochondrial microsatellite instability in patients with metastatic colorectal cancer
por: Venderbosch, S., et al.
Publicado: (2015) -
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021) -
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer
por: Cohen, Romain, et al.
Publicado: (2021)